Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Colorcon
US Army
Express Scripts
Healthtrust
Federal Trade Commission
UBS
Harvard Business School
Accenture

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,340,695

« Back to Dashboard

Which drugs does patent 6,340,695 protect, and when does it expire?

Patent 6,340,695 protects DICLEGIS and is included in one NDA.

This patent has forty-nine patent family members in thirty-six countries.
Summary for Patent: 6,340,695
Title: Rapid onset formulation
Abstract:Provided herein is a novel enterically-coated pyridoxine HCl and doxylamine succinate rapid onset formulation comprising a disintegrating agent such that the following dissolution profiles are satisfied when measured in 1000 ml phosphate buffer at pH 6.8 and 37.degree. C. in a type 2 dissolution apparatus at 100 rpm: (a) at least about 40% of the total pyridoxine HCl and doxylamine succinate is dissolved after 30 minutes of measurement; (b) at least about 70% of the total pyridoxine HCl and doxylamine succinate is dissolved after 60 minutes of measurement; (c) at least about 80% of the total pyridoxine HCl and doxylamine succinate is dissolved after 90 minutes of measurement; (d) at about 90% of the total pyridoxine HCl and doxylamine succinate is dissolved after 120 minutes of measurement. Preferably the formulation will contain a core coated with at least one enteric coating, the core comprising pyridoxine HCl, doxylamine succinate and the following non-active excipients: a filler or binder, a disintegrating agent, a lubricant, a silica flow conditioner and a stabilizing agent.
Inventor(s): Gervais; Eric (Laval, CA)
Assignee: Duchesnay Inc. (Laval, CA)
Application Number:09/885,051
Patent Claim Types:
see list of patent claims
Formulation; Compound; Device; Composition; Use;

Drugs Protected by US Patent 6,340,695

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Duchesnay DICLEGIS doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 021876-001 Apr 8, 2013 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y TREATMENT OF NAUSEA AND VOMITING OF PREGNANCY IN WOMEN WHO DO NOT RESPOND TO CONSERVATIVE MANAGEMENT ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,340,695

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland 204507 ➤ Subscribe
Poland 362763 ➤ Subscribe
Norway 332190 ➤ Subscribe
Norway 20022982 ➤ Subscribe
Netherlands 1020895 ➤ Subscribe
Mexico PA02006037 ➤ Subscribe
Monaco 200059 ➤ Subscribe
Luxembourg 90934 ➤ Subscribe
South Korea 100527985 ➤ Subscribe
South Korea 20030023612 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Novartis
Accenture
Julphar
Merck
Fuji
AstraZeneca
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot